nach oben

Erschienen in:

13.05.2019 | Review

Global prevalence of depression among breast cancer patients: a systematic review and meta-analysis

verfasst von: Motahare Pilevarzadeh, Mehrbanoo Amirshahi, Roghaiyeh Afsargharehbagh, Hosein Rafiemanesh, Seyed-Mehdi Hashemi, Abbas Balouchi

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Depression in patients with breast cancer imposes huge costs to patients, families, and healthcare systems. The present study aimed at evaluating the global prevalence depression among patients with breast cancer.

Methods

In this meta-analysis, three electronic databases (PubMed, Web of Science, and Scopus) were searched from 1 January, 2000 until 30 March, 2019. The Hoy tool was used to evaluate the quality of the articles included in the meta-analysis. The search, screening, quality evaluation, and data extraction were carried out by two of the researchers.

Results

Of 47,424 studies, 72 studies performed in 30 countries entered the final stage of analysis. The global prevalence of depression was 32.2%. Specifically, the prevalence of depression was highest in the Eastern Mediterranean region and twice as high in middle-income countries as compared to developed countries.

Conclusions

Regarding the high prevalence of depression in patients with breast cancer, it is vital to carry out screening within standard time periods and offer the necessary emotional support.

Observatory TGC (2018) GLOBOCAN. Breast Cancer 2019. http://gco.iarc.fr/today/data/factsheets/cancers/20-Breast-fact-sheet.pdf

Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA 69(1):7–34PubMed

Grunfeld E, Coyle D, Whelan T, Clinch J, Reyno L, Earle CC et al (2004) Family caregiver burden: results of a longitudinal study of breast cancer patients and their principal caregivers. CMAJ 170(12):1795–1801CrossRefPubMedPubMedCentral

Kale HP, Carroll NV (2016) Self-reported financial burden of cancer care and its effect on physical and mental health-related quality of life among US cancer survivors. Cancer 122(8):283–289CrossRefPubMed

care Co (2019) The costs of breast cancer in the U.S. https://costsofcare.org/the-costs-of-breast-cancer-in-the-u-s/

Ecclestone C, Chow R, Pulenzas N, Zhang L, Leahey A, Hamer J et al (2016) Quality of life and symptom burden in patients with metastatic breast cancer. Support Care Cancer 24(9):4035–4043CrossRefPubMed

McFarland DC, Shaffer KM, Tiersten A, Holland J (2018) Physical symptom burden and its association with distress, anxiety, and depression in breast cancer. Psychosomatics 59(5):464–471CrossRefPubMedPubMedCentral

Brunault P, Champagne AL, Huguet G, Suzanne I, Senon JL, Body G et al (2016) Major depressive disorder, personality disorders, and coping strategies are independent risk factors for lower quality of life in non-metastatic breast cancer patients. Psycho-Oncology 25(5):513–520CrossRefPubMed

Hopko DR, Clark C, Cannity K, Bell JL (2016) Pretreatment depression severity in breast cancer patients and its relation to treatment response to behavior therapy. Health Psychol 35(1):10CrossRefPubMed

10.

Jacob L, Bleicher L, Kostev K, Kalder M (2016) Prevalence of depression, anxiety and their risk factors in German women with breast cancer in general and gynecological practices. J Cancer Res Clin Oncol 142(2):447–452CrossRefPubMed

11.

Purkayastha D, Venkateswaran C, Nayar K, Unnikrishnan U (2017) Prevalence of depression in breast cancer patients and its association with their quality of life: a cross-sectional observational study. Indian J Palliat Care 23(3):268CrossRefPubMedPubMedCentral

12.

Caplette-Gingras A, Savard J (2008) Depression in women with metastatic breast cancer: a review of the literature. Palliat Support Care 6(4):377–387CrossRef

13.

Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 151(4):264–269CrossRefPubMed

14.

WHO (2019) Definition of regional groupings. https://www.who.int/healthinfo/global_burden_disease/definition_regions/en/

15.

Bank W (2019) How does the World Bank classify countries? https://databank.worldbank.org/data/source/world-development-indicators

16.

Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C et al (2012) Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol 65(9):934–939CrossRefPubMed

17.

Ahmed AE, Albalawi AN, Qureshey ET, Qureshey AT, Yenugadhati N, Al-Jahdali H et al (2018) Psychological symptoms in adult Saudi Arabian cancer patients: prevalence and association with self-rated oral health. Breast Cancer (Dove Medical Press) 10:153–159

18.

Akel R, El Darsa H, Anouti B, Mukherji D, Temraz S, Raslan R et al (2017) Anxiety, depression and quality of life in breast cancer patients in the levant. Asian Pac J Cancer Prev 18(10):2809–2816PubMedPubMedCentral

19.

Alacacioglu A, Yavuzsen T, Dirioz M, Yilmaz U (2009) Quality of life, anxiety and depression in Turkish breast cancer patients and in their husbands. Med Oncol (Northwood, London, England) 26(4):415–419CrossRef

20.

Alacacioglu A, Ulger E, Varol U, Yildiz I, Salman T, Bayoglu V et al (2014) Depression, anxiety and sexual satisfaction in breast cancer patients and their partners-Izmir oncology group study. Asian Pac J Cancer Prev 15(24):10631–10636CrossRefPubMed

21.

Ardebil MD, Bouzari Z, Shenas MH, Keighobadi M (2013) Depression and health related quality of life in breast cancer patients. JPMA 63(1):69–71PubMed

22.

Aukst-Margetic B, Jakovljevic M, Margetic B, Biscan M, Samija M (2005) Religiosity, depression and pain in patients with breast cancer. Gen Hosp Psychiatry 27(4):250–255CrossRefPubMed

23.

Bener A, Alsulaiman R, Doodson L, Agathangelou T (2017) Depression, hopelessness and social support among breast cancer patients: in highly endogamous population. Asian Pac J Cancer Prev 18(7):1889–1896PubMedPubMedCentral

24.

Carlson LE, Campbell TS, Garland SN, Grossman P (2007) Associations among salivary cortisol, melatonin, catecholamines, sleep quality and stress in women with breast cancer and healthy controls. J Behav Med 30(1):45–58CrossRefPubMed

25.

Chang HA, Barreto N, Davtyan A, Beier E, Cangin MA, Salman J et al (2019) Depression predicts longitudinal declines in social support among women with newly diagnosed breast cancer. Psycho-Oncology 28(3):635–642PubMedPubMedCentral

26.

Chang HY, Keyes KM, Mok Y, Jung KJ, Shin YJ, Jee SH (2015) Depression as a risk factor for overall and hormone-related cancer: the Korean cancer prevention study. J Affect Disord 173:1–8CrossRefPubMed

27.

Chen X, Zheng Y, Zheng W, Gu K, Chen Z, Lu W et al (2009) Prevalence of depression and its related factors among Chinese women with breast cancer. Acta Oncol (Stockholm, Sweden) 48(8):1128–1136CrossRef

28.

Christensen S, Zachariae R, Jensen AB, Vaeth M, Moller S, Ravnsbaek J et al (2009) Prevalence and risk of depressive symptoms 3-4 months post-surgery in a nationwide cohort study of Danish women treated for early stage breast-cancer. Breast Cancer Res Treat 113(2):339–355CrossRefPubMed

29.

Christie KM, Meyerowitz BE, Maly RC (2010) Depression and sexual adjustment following breast cancer in low-income Hispanic and non-Hispanic White women. Psycho-Oncology 19(10):1069–1077CrossRefPubMedPubMedCentral

30.

Couillet A, Tredan O, Oussaid N, Saltel P (2015) Prevalence of depressive syndrome in patients with breast cancer treated with or without aromatase inhibitors. Oncologie 17(11–12):587–594CrossRef

31.

Cvetković J, Nenadović M (2016) Depression in breast cancer patients. Psychiatry Res 240:343–347CrossRefPubMed

32.

De Medeiros MCL, Veiga DF, Neto MS, Abla LEF, Juliano Y, Ferreira LM (2010) Depression and conservative surgery for breast cancer. Clinics 65(12):1291–1294CrossRefPubMedPubMedCentral

33.

de Souza BF, de Moraes JA, Inocenti A, dos Santos MA, Silva A, Miasso AI (2014) Women with breast cancer taking chemotherapy: depression symptoms and treatment adherence. Revista Latino-Americana De Enfermagem 22(5):866–873CrossRefPubMedPubMedCentral

34.

Dujmović A, Marčinko D, Bulić K, Kisić H, Duduković M, Mijatović D (2017) Quality of life and depression among female patients undergoing surgical treatment for breast cancer: a prospective study. Psychiatr Danub 29(3):345–350CrossRefPubMed

35.

Eskelinen M, Ollonen P (2011) Beck Depression Inventory (BDI) in patients with breast disease and breast cancer: a prospective case-control study. In Vivo (Athens, Greece) 25(1):111–116

36.

Fafouti M, Paparrigopoulos T, Zervas Y, Rabavilas A, Malamos N, Liappas I et al (2010) Depression, anxiety and general psychopathology in breast cancer patients: a cross-sectional control study. In Vivo (Athens, Greece) 24(5):803–810

37.

Galloway SK, Baker M, Giglio P, Chin S, Madan A, Malcolm R et al (2012) Depression and anxiety symptoms relate to distinct components of pain experience among patients with breast cancer. Pain Res Treat 2012:851276PubMedPubMedCentral

38.

Geyikci R, Cakmak S, Demirkol ME, Uguz S (2018) Correlation of anxiety and depression levels with attitudes towards coping with illness and sociodemographic characteristics in patients with a diagnosis of breast cancer. Dusunen Adam-J Psychiatry Neurol Sci 31(3):246–257CrossRef

39.

Hegel MT, Moore CP, Collins ED, Kearing S, Gillock KL, Riggs RL et al (2006) Distress, psychiatric syndromes, and impairment of function in women with newly diagnosed breast cancer. Cancer 107(12):2924–2931CrossRefPubMed

40.

Hill J, Holcombe C, Clark L, Boothby MRK, Hincks A, Fisher J et al (2011) Predictors of onset of depression and anxiety in the year after diagnosis of breast cancer. Psychol Med 41(7):1429–1436CrossRefPubMed

41.

Ho SS, So WK, Leung DY, Lai ET, Chan CW (2013) Anxiety, depression and quality of life in Chinese women with breast cancer during and after treatment: a comparative evaluation. Eur J Oncol Nurs 17(6):877–882CrossRefPubMed

42.

Hopwood P, Sumo G, Mills J, Haviland J, Bliss JM (2010) The course of anxiety and depression over 5 years of follow-up and risk factors in women with early breast cancer: results from the UK Standardisation of Radiotherapy Trials (START). Breast 19(2):84–91CrossRefPubMed

43.

Huang CY, Guo SE, Hung CM, Shih SL, Lee LC, Hung GC et al (2010) Learned resourcefulness, quality of life, and depressive symptoms for patients with breast cancer. Oncol Nurs Forum 37(4):E280–E287CrossRefPubMed

44.

Jang JE, Kim SW, Kim SY, Kim JM, Park MH, Yoon JH et al (2013) Religiosity, depression, and quality of life in Korean patients with breast cancer: a 1-year prospective longitudinal study. Psycho-Oncology 22(4):922–929CrossRefPubMed

45.

Jimenez-Fonseca P, Calderon C, Hernandez R, Cajal TRY, Mut M, Ramchandani A et al (2018) Factors associated with anxiety and depression in cancer patients prior to initiating adjuvant therapy. Clin Trans Oncol 20(11):1408–1415CrossRefPubMed

46.

Jones SM, LaCroix AZ, Li W, Zaslavsky O, Wassertheil-Smoller S, Weitlauf J et al (2015) Depression and quality of life before and after breast cancer diagnosis in older women from the Women’s Health Initiative. J Cancer Surviv 9(4):620–629CrossRefPubMedPubMedCentral

47.

Kalender M, Buyukhatipoglu H, Balakan O, Suner A, Dirier A, Sevinc A et al (2014) Depression, anxiety and quality of life through the use of complementary and alternative medicine among breast cancer patients in Turkey. J Cancer Res Ther 10(4):962–966CrossRefPubMed

48.

Karakoyun-Celik O, Gorken I, Sahin S, Orcin E, Alanyali H, Kinay M (2010) Depression and anxiety levels in woman under follow-up for breast cancer: relationship to coping with cancer and quality of life. Med Oncol (Northwood, London, England) 27(1):108–113CrossRef

49.

Kim SY, Stewart R, Kim SW, Yang SJ, Kim JM, Shin IS et al (2012) Predictors of depression in Korean breast cancer patients: a one-year longitudinal study. Asia-Pacific Psychiatry 4(4):250–257CrossRef

50.

Kovács Z, Rigó AP, Szabó É, Sebestyén Á, Hoyer M, Fülöp E et al (2011) The prevalence of depression and anxiety in patients with malignant breast tumour. New Med 2011-January(2):61–6

51.

Kyranou M, Paul SM, Dunn LB, Puntillo K, Aouizerat BE, Abrams G et al (2013) Differences in depression, anxiety, and quality of life between women with and without breast pain prior to breast cancer surgery. Eur J Oncol Nurs 17(2):190–195CrossRefPubMed

52.

Lee MK, Park S, Lee ES, Ro J, Kang HS, Shin KH et al (2011) Social support and depressive mood 1 year after diagnosis of breast cancer compared with the general female population: a prospective cohort study. Support Care Cancer 19(9):1379–1392CrossRefPubMed

53.

Linden W, Vodermaier A, MacKenzie R, Greig D (2012) Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord 141(2–3):343–351CrossRefPubMed

54.

Lueboonthavatchai P (2007) Prevalence and psychosocial factors of anxiety and depression in breast cancer patients. J Med Assoc Thai 90(10):2164–2174PubMed

55.

Marijanovic I, Pavlekovic G, Buhovac T, Martinac M (2017) The relationship between health locus of control, depression, and sociodemographic factors and amount of time breast cancer patients wait before seeking diagnosis and treatment. Psychiatria Danubina 29(3):330–344CrossRefPubMed

56.

Mashhadi MA, Shakiba M, Zakeri Z (2013) Evaluation of depression in patients with cancer in South of iran (zahedan). Iran J Cancer Prev 6(1):12–16PubMedPubMedCentral

57.

Mhaidat NM, Alzoubi KH, Al-Sweedan S, Alhusein BA (2009) Prevalence of depression among cancer patients in Jordan: a national survey. Support Care Cancer 17(11):1403–1407CrossRefPubMed

58.

Milbury K, Badr H (2013) Sexual problems, communication patterns, and depressive symptoms in couples coping with metastatic breast cancer. Psycho-Oncology 22(4):814–822CrossRefPubMed

59.

Miura K, Ando S, Imai T (2016) The association of cognitive fatigue with menopause, depressive symptoms, and quality of life in ambulatory breast cancer patients. Breast Cancer 23(3):407–414CrossRefPubMed

60.

Montazeri A, Jarvandi S, Haghighat S, Vahdani M, Sajadian A, Ebrahimi M et al (2001) Anxiety and depression in breast cancer patients before and after participation in a cancer support group. Patient Educ Couns 45(3):195–198CrossRefPubMed

61.

Montazeri A, Harirchi I, Vahdani M, Khaleghi F, Jarvandi S, Ebrahimi M et al (2000) Anxiety and depression in Iranian breast cancer patients before and after diagnosis. Eur J Cancer Care 9(3):151–157CrossRefPubMed

62.

Montazeri A, Sajadian A, Ebrahimi M, Akbari ME (2005) Depression and the use of complementary medicine among breast cancer patients. Support Care Cancer 13(5):339–342CrossRefPubMed

63.

Ng GC, Mohamed S, Sulaiman AH, Zainal NZ (2017) Anxiety and depression in cancer patients: the association with religiosity and religious coping. J Relig Health 56(2):575–590CrossRefPubMed

64.

Ollonen P, Lehtonen J, Eskelinen M (2005) Anxiety, depression, and the history of psychiatric symptoms in patients with breast disease: a prospective case-control study in Kuopio, Finland. Anticancer Res 25(3c):2527–2533PubMed

65.

Park B, Youn S, Vi KK, Lee SY, Lee JS, Chung S (2017) The prevalence of depression among patients with the top ten most common cancers in South Korea. Psychiatry Investig 14(5):618–625CrossRefPubMedPubMedCentral

66.

Park EM, Gelber S, Rosenberg SM, Seah DSE, Schapira L, Come SE et al (2018) Anxiety and depression in young women with metastatic breast cancer: a cross-sectional study. Psychosomatics 59(3):251–258CrossRefPubMedPubMedCentral

67.

Popoola AO, Adewuya AO (2012) Prevalence and correlates of depressive disorders in outpatients with breast cancer in Lagos, Nigeria. Psycho-Oncology 21(6):675–679CrossRefPubMed

68.

Puigpinos-Riera R, Graells-Sans A, Serral G, Continente X, Bargallo X, Domenech M et al (2018) Anxiety and depression in women with breast cancer: social and clinical determinants and influence of the social network and social support (DAMA cohort). Cancer Epidemiol 55:123–129CrossRefPubMed

69.

Purkayastha D, Venkateswaran C, Nayar K, Unnikrishnan UG (2017) Prevalence of depression in breast cancer patients and its association with their quality of life: a cross-sectional observational study. Indian J Palliat Care 23(3):268–273CrossRefPubMedPubMedCentral

70.

Reece JC, Chan YF, Herbert J, Gralow J, Fann JR (2013) Course of depression, mental health service utilization and treatment preferences in women receiving chemotherapy for breast cancer. Gen Hosp Psychiatry 35(4):376–381CrossRefPubMed

71.

Reuter K, Classen CC, Roscoe JA, Morrow GR, Kirshner JJ, Rosenbluth R et al (2006) Association of coping style, pain, age and depression with fatigue in women with primary breast cancer. Psycho-Oncology 15(9):772–779CrossRefPubMed

72.

Saboonchi F, Petersson LM, Wennman-Larsen A, Alexanderson K, Brannstrom R, Vaez M (2014) Changes in caseness of anxiety and depression in breast cancer patients during the first year following surgery: patterns of transiency and severity of the distress response. Eur J Oncol Nurs 18(6):598–604CrossRefPubMed

73.

Schleife H, Sachtleben C, Finck Barboza C, Singer S, Hinz A (2014) Anxiety, depression, and quality of life in German ambulatory breast cancer patients. Breast Cancer 21(2):208–213CrossRefPubMed

74.

Shakeri J, Golshani S, Jalilian E, Farnia V, Nooripour R, Alikhani M et al (2016) Studying the amount of depression and its role in predicting the quality of life of women with breast cancer. Asian Pac J Cancer Prev 17(2):643–646CrossRefPubMed

75.

Sharma A, Zhang JP (2015) Depression and its predictors among breast cancer patients in nepal. Asean J Psychiatry 16(1):106–115

76.

Sheppard VB, Llanos AA, Hurtado-de-Mendoza A, Taylor TR, Adams-Campbell LL (2013) Correlates of depressive symptomatology in African-American breast cancer patients. J Cancer Surviv 7(3):292–299CrossRefPubMedPubMedCentral

77.

Slovacek L, Slovackova B, Slanska I, Petera J, Priester P, Filip S et al (2009) Depression symptoms and health-related quality of life among patients with metastatic breast cancer in programme of palliative cancer care. Neoplasma 56(6):467–472CrossRefPubMed

78.

So WK, Marsh G, Ling WM, Leung FY, Lo JC, Yeung M et al (2010) Anxiety, depression and quality of life among Chinese breast cancer patients during adjuvant therapy. Eur J Oncol Nurs14(1):17–22CrossRefPubMed

79.

Stafford L, Judd F, Gibson P, Komiti A, Mann GB, Quinn M (2013) Screening for depression and anxiety in women with breast and gynaecologic cancer: course and prevalence of morbidity over 12 months. Psycho-Oncology 22(9):2071–2078CrossRefPubMed

80.

Stanton AL, Wiley JF, Krull JL, Crespi CM, Hammen C, Allen JJB et al (2015) Depressive episodes, symptoms, and trajectories in women recently diagnosed with breast cancer. Breast Cancer Res Treat 154(1):105–115CrossRefPubMedPubMedCentral

81.

Steiner JL, Wagner CD, Bigatti SM, Storniolo AM (2014) Depressive rumination and cognitive processes associated with depression in breast cancer patients and their spouses. Fam Syst Health 32(4):378–388CrossRefPubMedPubMedCentral

82.

Su JA, Yeh DC, Chang CC, Lin TC, Lai CH, Hu PY et al (2017) Depression and family support in breast cancer patients. Neuropsychiatr Dis Treat 13:2389–2396CrossRefPubMedPubMedCentral

83.

Tsaras K, Papathanasiou IV, Mitsi D, Veneti A, Kelesi M, Zyga S et al (2018) Assessment of depression and anxiety in breast cancer patients: prevalence and associated factors. Asian Pac J Cancer Prev 19(6):1661–1669PubMedPubMedCentral

84.

Vin-Raviv N, Akinyemiju TF, Galea S, Bovbjerg DH (2015) Depression and anxiety disorders among hospitalized women with breast cancer. PLoS ONE 10(6):e0129169CrossRefPubMedPubMedCentral

85.

Walker J, Hansen CH, Martin P, Symeonides S, Ramessur R, Murray G et al (2014) Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: a cross-sectional analysis of routinely collected clinical data. Lancet Psychiatry 1(5):343–350CrossRefPubMed

86.

Wu SM, Yang HC, Thayer JF, Andersen BL (2014) Association of the physiological stress response with depressive symptoms in patients with breast cancer. Psychosom Med 76(4):252–256CrossRefPubMedPubMedCentral

87.

Zhang J, Zhou Y, Feng Z, Xu Y, Zeng G (2018) Longitudinal trends in anxiety, depression, and quality of life during different intermittent periods of adjuvant breast cancer chemotherapy. Cancer Nurs 41(1):62–68CrossRefPubMed

88.

Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C et al (2011) Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 12(2):160–174CrossRefPubMed

89.

Hotopf M, Chidgey J, Addington-Hall J, Ly KL (2002) Depression in advanced disease: a systematic review Part 1. Prevalence and case finding. Palliat Med 16(2):81–97CrossRef

90.

Krebber A, Buffart L, Kleijn G, Riepma I, De Bree R, Leemans C et al (2014) Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psycho-Oncology 23(2):121–130CrossRefPubMed

91.

Aryankhesal A, Ghashghaee A, Sardari E, Mahmoudi S, Alihosseini S, Dehnad A et al (2019) Prevalence of depression in patients with cancer in Iran: a systematic review and meta-analysis. BMJ Support Palliat Care bmjspcare-2018-001724

92.

93.

Massie MJ (2004) Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr 32:57–71CrossRef

94.

Im Song J, Shin DW, Choi JY, Kang J, Baik YJ, Mo H et al (2011) Quality of life and mental health in family caregivers of patients with terminal cancer. Support Care Cancer 19(10):1519CrossRef

95.

Vitaliano PP, Zhang J, Scanlan JM (2003) Is caregiving hazardous to one’s physical health? A meta-analysis. Psychol Bull 129(6):946CrossRefPubMed

96.

Watts S, Leydon G, Birch B, Prescott P, Lai L, Eardley S et al (2014) Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates. BMJ Open 4(3):e003901CrossRefPubMedPubMedCentral

97.

Watts S, Prescott P, Mason J, McLeod N, Lewith G (2015) Depression and anxiety in ovarian cancer: a systematic review and meta-analysis of prevalence rates. BMJ Open 5(11):e007618CrossRefPubMedPubMedCentral

98.

Caruso R, Nanni MG, Riba M, Sabato S, Mitchell A, Croce E et al (2017) Depressive spectrum disorders in cancer: prevalence, risk factors and screening for depression: a critical review. Acta Oncol 56(2):146–155CrossRefPubMed

99.

Begovic-Juhant A, Chmielewski A, Iwuagwu S, Chapman LA (2012) Impact of body image on depression and quality of life among women with breast cancer. J Psychosoc Oncol 30(4):446–460CrossRefPubMed

100.

Collins KK, Liu Y, Schootman M, Aft R, Yan Y, Dean G et al (2011) Effects of breast cancer surgery and surgical side effects on body image over time. Breast Cancer Res Treat 126(1):167–176CrossRefPubMed

101.

Przezdziecki A, Sherman KA, Baillie A, Taylor A, Foley E, Stalgis-Bilinski K (2013) My changed body: breast cancer, body image, distress and self-compassion. Psycho-Oncology 22(8):1872–1879CrossRefPubMed

102.

103.

Alemayehu M, Deyessa N, Medihin G, Fekadu A (2018) A descriptive analysis of depression and pain complaints among patients with cancer in a low income country. PLoS ONE 13(3):e0193713CrossRefPubMedPubMedCentral

104.

Ell K, Sanchez K, Vourlekis B, Lee P-J, Dwight-Johnson M, Lagomasino I et al (2005) Depression, correlates of depression, and receipt of depression care among low-income women with breast or gynecological cancer. J Clin Oncol 23(13):3052CrossRefPubMed

105.

Klein J, Hofreuter-Gätgens K, Lüdecke D, Fisch M, Graefen M, von dem Knesebeck O (2016) Socioeconomic status and health-related quality of life among patients with prostate cancer 6 months after radical prostatectomy: a longitudinal analysis. BMJ Open 6(6):e010968CrossRefPubMedPubMedCentral

Titel: Global prevalence of depression among breast cancer patients: a systematic review and meta-analysis
verfasst von: Motahare Pilevarzadeh
Mehrbanoo Amirshahi
Roghaiyeh Afsargharehbagh
Hosein Rafiemanesh
Seyed-Mehdi Hashemi
Abbas Balouchi
Publikationsdatum: 13.05.2019
Verlag: Springer US
Erschienen in: Breast Cancer Research and Treatment / Ausgabe 3/2019
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-019-05271-3

Neu im Fachgebiet Onkologie

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Global prevalence of depression among breast cancer patients: a systematic review and meta-analysis

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Onkologie

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Stufenschema weist Prostatakarzinom zuverlässig nach

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2019

Microinvasion: could it be sufficient diagnostic criteria for the optimal treatment decision?

Surrogate threshold effect based on a meta-analysis for the predictive value of progression-free survival for overall survival in hormone receptor-positive, HER2-negative metastatic breast cancer

Prediction of axillary pathologic response with breast pathologic complete response after neoadjuvant chemotherapy

Patterns of adjuvant care and outcomes of elderly women with stage I breast cancer after breast-conserving surgery: a population-based analysis

Management of toxicities associated with targeted therapies for HR-positive metastatic breast cancer: a multidisciplinary approach is the key to success

Clinical and analytical validation of Ki-67 in 9069 patients from IBCSG VIII + IX, BIG1-98 and GeparTrio trial: systematic modulation of interobserver variance in a comprehensive in silico ring trial

Neu im Fachgebiet Onkologie

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Stufenschema weist Prostatakarzinom zuverlässig nach

Update Onkologie